1378 Discovery and characterization of PM-4321, a selective inhibitor of the aryl hydrocarbon receptor (AHR) with anti-tumor immunomodulatory effects

• Charles Sinclair,
• Luisa Salter-Cid,
• Benjamin Carter,
• Ming Bai,
• Christopher Wrocklage,
• Kritika Ramani,
• Anna Nicole Bosco,
• Iulian Pruteanu-Malinici,
• Lizeth Perales,
• Wojciech Dworakowski,
• Brenda K Eustace,
• Kun Don Yi,
• Seema Kumar,
• Matthew Abbinanti,
• Alessandra Bartolozzi,
• John Robert Proudfoot,
• Timothy Briggs,
• John Steven Taylor,
• Sheila Ranganath

Affiliations

Charles Sinclair

3Bristol-Myers Squibb, Cambridge, MA, USA

Luisa Salter-Cid

1Flagship Pioneering, Cambridge, MA, USA

Benjamin Carter

1Flagship Pioneering, Cambridge, MA, USA

Ming Bai

1Flagship Pioneering, Cambridge, MA, USA

Christopher Wrocklage

2Pioneering Medicines, Cambridge MA

Kritika Ramani

1Flagship Pioneering, Cambridge, MA, USA

Anna Nicole Bosco

1Flagship Pioneering, Cambridge, MA, USA

Iulian Pruteanu-Malinici

1Flagship Pioneering, Cambridge, MA, USA

Lizeth Perales

1Flagship Pioneering, Cambridge, MA, USA

Wojciech Dworakowski

1Flagship Pioneering, Cambridge, MA, USA

Brenda K Eustace

1Flagship Pioneering, Cambridge, MA, USA

Kun Don Yi

1Flagship Pioneering, Cambridge, MA, USA

Seema Kumar

1Flagship Pioneering, Cambridge, MA, USA

Matthew Abbinanti

1Flagship Pioneering, Cambridge, MA, USA

Alessandra Bartolozzi

4Bartolozzi Consulting LLC, Gladwyne, PA, USA

John Robert Proudfoot

5Discoverybytes LLC, Newtown, CT, USA

Timothy Briggs

6Kintai Therapeutics, Cambridge, MA, USA

John Steven Taylor

6Kintai Therapeutics, Cambridge, MA, USA

Sheila Ranganath

1Flagship Pioneering, Cambridge, MA, USA